Calendar

Events that a source expects, grouped by the month, quarter or half-year the source names, with who expected each and when they said so.

Upcoming as of , the date this release was built (the newest input commit date), not today's date. An expected date is a statement by the source, not a result, and it can move. Dated events are on the timeline.

8,817 of these dates come from registry records: the start, primary completion or completion that a registry expects of a trial. A program assembled them, and a registry often leaves a date unchanged after it has passed. The calendar file lists the dates of written pages only.

Add to your calendar (calendar.ics)

The calendar file has one all-day event for each upcoming item. Where a source gives only a month, a quarter, a half-year or a year, the event sits on the first day of that period and its title says "expected sometime in" the period.

Upcoming

December 2029 125

  1. Study completion The Fourth Left Atrial Appendage Occlusion Study Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05963698

  2. Study completion Medical Management With Endovascular Thrombectomy Versus Medical Management Alone in Patients Presenting Beyond 24 Hours of Last Known Well Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07115940

  3. Study completion Effects of Vibration-Assisted Physical Activity in Type-2 Diabetes Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07350473

  4. Study completion Tirzepatide on Atrial Fibrillation Recurrence After Catheter Ablation in Patients With Obesity and HFpEF Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07630454

  5. Study completion RESCUE: PCSK9 Inhibitors for Carotid Vulnerable Plaque Remodeling Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07819643

  6. Primary completion Recombinant Human Prourokinase for Acute Ischemic Stroke in the Extended Window Selected by CT-Based Artificial Intelligence Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07901842

  7. Primary completion Tenecteplase Bridging Thrombolysis Prior to Inter-hospital Transfer for Endovascular Therapy in Anterior Circulation Large Vessel Occlusion Stroke Within 4.5-24 Hours Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07912970

  8. Primary completion Artificial Intelligence-enabled Management of Atrial Fibrillation(ABLE-AF Trial) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07938281

  9. Study completion Visceral Manifold and Unitary Device Study for the Repair of Thoracoabdominal Aortic Aneurysms Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02294435

  10. Study completion Avoiding Anticoagulation After IntraCerebral Haemorrhage Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03243175

  11. Study completion Blockade of the Renin-angiotensin-aldosterone System in Patients With ARVD Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03593317

  12. Study completion Statins In Intracerbral Hemorrhage Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03936361

  13. Study completion Comparison of LAA-Closure vs Oral Anticoagulation in Patients With NVAF and Status Post Intracranial Bleeding. Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04298723

  14. Study completion Low Dose ColchicinE in pAtients With Peripheral Artery DiseasE to Address Residual Vascular Risk Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04774159

  15. Primary completion Low Dose ColchicinE in pAtients With Peripheral Artery DiseasE to Address Residual Vascular Risk Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04774159

  16. Study completion Proact: A Study of REACT in Subjects With Type 2 Diabetes Mellitus and Chronic Kidney Disease Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05099770

  17. Primary completion Proact: A Study of REACT in Subjects With Type 2 Diabetes Mellitus and Chronic Kidney Disease Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05099770

  18. Study completion Improving Cerebral Blood Flow and Cognition in Patients with Cerebral Small Vessel Disease. the ETLAS-2 Trial Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05173896

  19. Study completion SAVE-FistulaS: the SelfWrap-Assisted ArterioVEnous Fistulas Study Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06001827

  20. Study completion Long-Term Safety and Efficacy of Tegoprubart in Kidney Transplant Recipients Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06126380

  21. Primary completion Long-Term Safety and Efficacy of Tegoprubart in Kidney Transplant Recipients Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06126380

  22. Study completion Synchronized Diaphragmatic Stimulation in Symptomatic Heart Failure Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06552637

  23. Study completion ReVeRA-301: Etripamil in Atrial Fibrillation Phase 3 Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06716021

  24. Study completion Clinical Trial Evaluating the Safety and Efficacy of Artificial Polymer Heart Valve for the Treatment of Aortic Valve Disease Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06737757

  25. Study completion BoxX-NoAF Clinical Trial Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06989775

  26. Study completion Early Double Sequential Defibrillation in Out of Hospital Cardiac Arrest Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07174986

  27. Study completion Epicardial Adipose Tissue Composition and Heart Failure With Preserved Ejection Fraction Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07178145

  28. Study completion OPTION-EMEA Clinical Trial Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07349121

  29. Study completion An Adaptive Program of IKT-001 in Pulmonary Arterial Hypertension (PAH) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07365332

  30. Study completion ANAKINRA IN THE TREATMENT OF PEDIATRIC ACUTE MYOCARDITIS Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07371689

  31. Primary completion ANAKINRA IN THE TREATMENT OF PEDIATRIC ACUTE MYOCARDITIS Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07371689

  32. Study completion Flecainide Safety in Patients With Coronary Artery Disease and Atrial Fibrillation Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07405671

  33. Primary completion Flecainide Safety in Patients With Coronary Artery Disease and Atrial Fibrillation Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07405671

  34. Study completion The Southern-Norway Post-Stroke Atrial Fibrillation Study Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07407790

  35. Primary completion Pivotal Trial to Evaluate TraNsvenous TrIcuspid Valve ReplacemenT With LuX-Valve Plus System (The TRINITY Pivotal Trial) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07454980

  36. Study completion Safety and Efficacy of Low-dose Anticoagulation With Argatroban and Enoxaparin on ECMO Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07499037

  37. Study completion Role of Neuroinflammation and Blood-Brain Barrier Breakdown in Intracerebral Hemorrhage. Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07583147

  38. Study completion A Study to See if Lepodisiran Can Reduce Plaque in Coronary Arteries of Adults With Elevated Lp(a) Who Have Had Heart Events or Are at High Risk Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07613294

  39. Primary completion A Study to See if Lepodisiran Can Reduce Plaque in Coronary Arteries of Adults With Elevated Lp(a) Who Have Had Heart Events or Are at High Risk Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07613294

  40. Study completion Intravenous Iron to Improve Symptoms, Quality of Life and Exercise Capacity in HFpEF With Iron Deficiency Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07643818

  41. Primary completion Evaluation of the Safety and Effectiveness of the Globe® Pulsed Field System for Treating Patients With Symptomatic Paroxysmal Atrial Fibrillation Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07714876

  42. Study completion Digital Long-term Follow-up of Patients With Coronary Artery Disease Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07720349

  43. Primary completion DCB Outcomes After Non-Compliant Balloon Vessel Preparation With or Without Scoring in Patients With Femoropopliteal Arterial Disease Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07764016

  44. Primary completion Negative Pressure Wound Therapy Devices in Total Knee Arthroplasty Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07770633

  45. Study completion A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, Type 2 Diabetes, and Increased Cardiovascular Risk Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07900633

  46. Study completion Unipolar Voltage-Guided Substrate Modification Plus Pulsed Field Ablation Pulmonary Vein Isolation Versus Pulmonary Vein Isolation Alone in Persistent Atrial Fibrillation Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07926854

  47. Study completion Leadless Versus Conventional Pacemakers: Effects on Heart Function and Heart Failure Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07929467

  48. Primary completion Leadless Versus Conventional Pacemakers: Effects on Heart Function and Heart Failure Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07929467

  49. Primary completion Personalized Antiplatelet Therapy to Prevent Recurrent Cardiovascular Events in After Ischemic Stroke Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07943026

  50. Primary completion Conduction System Pacing Versus Conventional Right Ventricular Pacing in Adults With Atrioventricular Block Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07945860

  51. Primary completion BHB-1893 vs. Placebo for Symptomatic Non-obstructive Hypertrophic Cardiomyopathy Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07946107

  52. Study completion PARTNER 3 trial

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: PARTNER 3 Trial: Safety and Effectiveness of the SAPIEN 3 Transcatheter Heart Valve in Low Risk Patients With Aortic Stenosis

  53. Study completion Outcome in Patients Treated With Endovascular Thrombectomy - optIMAL Blood Pressure Control 2 (OPTIMAL-BP 2) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06677970

  54. Primary completion Outcome in Patients Treated With Endovascular Thrombectomy - optIMAL Blood Pressure Control 2 (OPTIMAL-BP 2) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06677970

  55. Study completion A Phase III Study to Evaluate the Efficacy and Safety of of DR10624 in Subjects With Severe Hypertriglyceridemia Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07693777

  56. Study completion PERSEVERE- A Trial to Evaluate AMDS in Acute DeBakey Type I Dissection Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05174767

  57. Study completion Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07626411

  58. Primary completion Polypill and RiscOMeter to Prevent StrOke and CogniTive ImpairmEnt (PROMOTE) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05155137

  59. Primary completion EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07064473

  60. Study completion Cilostazol With Nimodipine to Improve Outcome After Aneurysmal Subarachnoid Hemorrhage Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07144956

  61. Primary completion Cilostazol With Nimodipine to Improve Outcome After Aneurysmal Subarachnoid Hemorrhage Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07144956

  62. Study completion TicAgreLor Versus Placebo to Prevent Cerebral ISCHemia in anEuRysmal Low Grade SAH A Double Blinded Randomised Controlled Study Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07821008

  63. Primary completion TicAgreLor Versus Placebo to Prevent Cerebral ISCHemia in anEuRysmal Low Grade SAH A Double Blinded Randomised Controlled Study Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07821008

  64. Study completion Tenecteplase for Acute Ischemic Stroke Within 4.5 to 6 Hours of Onset (EXIT-BT2) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06010628

  65. Primary completion Tenecteplase for Acute Ischemic Stroke Within 4.5 to 6 Hours of Onset (EXIT-BT2) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06010628

  66. Study completion A Study to Evaluate Cenvacibart (REGN7508) for Secondary Stroke Prevention in Adult Participants Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07876492

  67. Primary completion A Study to Evaluate Cenvacibart (REGN7508) for Secondary Stroke Prevention in Adult Participants Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07876492

  68. Study completion Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06677060

  69. Primary completion Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06677060

  70. Primary completion A Research Study Looking at Kidney and Heart Health in Adults With Type 2 Diabetes and Chronic Kidney Disease Treated With Semaglutide in China Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07900438

  71. Study completion EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07064473

  72. Study completion SPYRAL GEMINI Pilot Study Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06907147

  73. Primary completion SPYRAL GEMINI Pilot Study Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06907147

  74. Study completion CRIC Combined With MFT for Cardiovascular Adverse Events in Patients With Incomplete Revascularization of CAD Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06820970

  75. Primary completion Colchicine Treatment for Non-Flow-Limiting Coronary Plaque by Coronary CTA: A Randomized Controlled Trial Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07349875

  76. Study completion Combination Antithrombotic Treatment for Prevention of Recurrent Ischemic Stroke in IntraCranial Atherosclerotic diseaSe (CATIS- ICAS) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07468448

  77. Primary completion Combination Antithrombotic Treatment for Prevention of Recurrent Ischemic Stroke in IntraCranial Atherosclerotic diseaSe (CATIS- ICAS) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07468448

  78. Study completion Effect of Tirzepatide on Recurrence of Atrial Fibrillation After Catheter Ablation in Obese Patients Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07715929

  79. Primary completion Dentate-Targeted Temporal Interference Stimulation for Post-Stroke Dysphagia Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07766668

  80. Study completion Effect of Xenon on Brain Injury After Aneurysmal Subarachnoid Hemorrhage Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04696523

  81. Primary completion Effect of Xenon on Brain Injury After Aneurysmal Subarachnoid Hemorrhage Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04696523

  82. Study completion Xeltis Hemodialysis Access Graft: aXess Pivotal Study Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05473299

  83. Study completion The Chronic Kidney Disease Adaptive Platform Trial Investigating Various Agents for Therapeutic Effect Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06058585

  84. Primary completion The Chronic Kidney Disease Adaptive Platform Trial Investigating Various Agents for Therapeutic Effect Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06058585

  85. Study completion Brain STimulation for Arm Recovery After Stroke 2 Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06265766

  86. Study completion RAFT - Pace &Ablate Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06299514

  87. Primary completion Cerebrolysin After Reperfusion in Extended-window EndoVascular Thrombectomy Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06339411

  88. Primary completion Stroke Prevention in Nigeria 2 Trial Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06526117

  89. Study completion Genotype-Guided Abbreviated DAPT Versus Un-Guided De-escalation Therapy in Patients With ACS and HBR Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06763744

  90. Study completion Early Initiated Ambulance-delivered Levetiracetam and Headposition in Hyper-acute Stroke Trial Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06773364

  91. Study completion Discontinuation of Anticoagulation With Intensive Rhythm Monitoring in Post-ablation Patients With Atrial Fibrillation Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06871228

  92. Primary completion Discontinuation of Anticoagulation With Intensive Rhythm Monitoring in Post-ablation Patients With Atrial Fibrillation Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06871228

Overdue

The expected date has passed and no published record says the event happened. This does not mean it failed or was delayed: the atlas may not have checked the source since. Oldest first.

  1. Study start Cilostazol With Nimodipine to Improve Outcome After Aneurysmal Subarachnoid Hemorrhage Registry record

    Expected 2025-12-15; that period ended on 2025-12-15.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07144956

  2. Study start Bovis Calculus Stativus Treat Acute Cerebral Ischemic Stroke With Impaired Consciousness Registry record

    Expected 2025-12-15; that period ended on 2025-12-15.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07240467

  3. Study start DPP4 Inhibitor Intervention on Post-stroke Cognitive Impairment in Ischemic Stroke Patients With Type 2 Diabetes Registry record

    Expected 2025-12-15; that period ended on 2025-12-15.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07241897

  4. Study start CLEAR Trial: CA330 Cytokine Adsorption Column for Anticoagulant/Antiplatelet Patients in Non-Elective CPB Surgery. Registry record

    Expected 2025-12-15; that period ended on 2025-12-15.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07284199

  5. Primary completion French eCLIPs™ Efficacy and Safety Investigation Registry record

    Expected 2025-12-16; that period ended on 2025-12-16.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05330897

  6. Study start A Multicenter Randomized Controlled Trial of Echocardiography-Guided Atrial Septal Defect Closure Performed in a Mobile Surgical Unit Registry record

    Expected 2025-12-19; that period ended on 2025-12-19.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07273227

  7. Study completion A Postmarket Clinical Trial for EXCROSSAL Stent in CAD Patients With 3-month DAPT or 12-month DAPT Registry record

    Expected 2025-12-20; that period ended on 2025-12-20.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03716011

  8. Study completion Single Catheter Primary Percutaneous Coronary Intervention Method in Patients With ST Elevation Myocardial Infarction Registry record

    Expected 2025-12-20; that period ended on 2025-12-20.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05604976

  9. Study completion Vagal Nerve Stimulation for the Treatment of Persistent AF Registry record

    Expected 2025-12-20; that period ended on 2025-12-20.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05833373

  10. Study completion Ticagrelor Versus Cilostazol in Ischemic Stroke Registry record

    Expected 2025-12-20; that period ended on 2025-12-20.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06561867

  11. Study start A Comparison of Effectiveness, Safety, and Cost-effectiveness of Dapagliflozin and Empagliflozin in Patients With Type 2 Diabetes Mellitus and High Body Mass Index (BMI) Registry record

    Expected 2025-12-24; that period ended on 2025-12-24.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07311551

  12. Study completion PRAGUE-25 Trial. Catheter Ablation vs. AADs and Risk Factor Modification. Registry record

    Expected 2025-12-30; that period ended on 2025-12-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04011800

  13. Study completion Air Pollution (PM2.5) on Accelerated Atherosclerosis: A Montelukast Interventional Study in Modernizing China Registry record

    Expected 2025-12-30; that period ended on 2025-12-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04762472

  14. Study completion Peri-treatment of SGLT-2 Inhibitor on Myocardial Infarct Size and Remodeling Index in Patients With Acute Myocardial Infarction and High Risk of Heart Failure Undergoing Percutaneous Coronary Intervention Registry record

    Expected 2025-12-30; that period ended on 2025-12-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04899479

  15. Primary completion DEX vs SEVO in Congenital Heart Surgery Registry record

    Expected 2025-12-30; that period ended on 2025-12-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05369949

  16. Study completion Efficacy and Safety of Semaglutide Injection in Subjects With Type 2 Diabetes Registry record

    Expected 2025-12-30; that period ended on 2025-12-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06339086

  17. Study completion Effect of Olive Leaf Extracts on Endothelial Dysfunction in Patients With Acute Coronary Syndrome Registry record

    Expected 2025-12-30; that period ended on 2025-12-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06723002

  18. Primary completion Effect of Olive Leaf Extracts on Endothelial Dysfunction in Patients With Acute Coronary Syndrome Registry record

    Expected 2025-12-30; that period ended on 2025-12-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06723002

  19. Study completion Efficacy and Safety of SPC1001 in Patients With Essential Hypertension Registry record

    Expected 2025-12-30; that period ended on 2025-12-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06826872

  20. Primary completion The Effectiveness and Safety of the Coronary Artery Serrated Cutting Balloon Dilation Catheter in the Pre-dilation of Coronary Artery Stenosis Lesions Registry record

    Expected 2025-12-30; that period ended on 2025-12-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06926400

  21. Study start Study on the Safety and Effectiveness of a Biodegradable Patent Foramen Ovale Occluder System Registry record

    Expected 2025-12-30; that period ended on 2025-12-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07300358

  22. Study start Effects of Henagliflozin Proline and Metformin XR on Body Composition in Geriatric Patients With Newly Diagnosed T2DM Registry record

    Expected 2025-12-30; that period ended on 2025-12-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07323381

  23. Primary completion Post Stroke Motor Learning Registry record

    Expected 2025-12; that period ended on 2025-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01519843

  24. Primary completion Impact of Non-invasive Brain Stimulation on Motor Recuperation Registry record

    Expected 2025-12; that period ended on 2025-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01544699

  25. Study completion Artisan Aphakia Lens for the Correction of Aphakia in Children Registry record

    Expected 2025-12; that period ended on 2025-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01547442

  26. Primary completion Artisan Aphakia Lens for the Correction of Aphakia in Children Registry record

    Expected 2025-12; that period ended on 2025-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01547442

  27. Study completion A Clinical Trial of STAtin Therapy for Reducing Events in the Elderly (STAREE) Registry record

    Expected 2025-12; that period ended on 2025-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02099123

  28. Primary completion A Clinical Trial of STAtin Therapy for Reducing Events in the Elderly (STAREE) Registry record

    Expected 2025-12; that period ended on 2025-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02099123

  29. Primary completion Improving Bi-manual Activities in Stroke Patients With Application of Neuro-stimulation Registry record

    Expected 2025-12; that period ended on 2025-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02308852

  30. Study completion A Study to Evaluate the Efficacy and Safety of BuMA Supreme Drug Eluting Stent(DES) Registry record

    Expected 2025-12; that period ended on 2025-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02698839

  31. Study completion A Study to Evaluate the Efficacy and Safety of BuMA Supreme Drug Eluting Stent(DES) Registry record

    Expected 2025-12; that period ended on 2025-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02698852

  32. Primary completion NT-proBNP Selected Prevention of Cardiac Events in Diabetic Patients Registry record

    Expected 2025-12; that period ended on 2025-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02817360

  33. Study completion RelayPro Thoracic Stent-Graft in Subjects With Thoracic Aortic Aneurysms and Penetrating Atherosclerotic Ulcers Registry record

    Expected 2025-12; that period ended on 2025-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02818972

  34. Study completion Inpatient Blood Glucose Control in Taichung Veterans General Hospital Registry record

    Expected 2025-12; that period ended on 2025-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02885909

  35. Study completion Evaluation of Decreased Usage of Betablockers After Myocardial Infarction in the SWEDEHEART Registry (REDUCE-SWEDEHEART) Registry record

    Expected 2025-12-31; that period ended on 2025-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03278509

  36. Study completion Intravascular Imaging- Versus Angiography-Guided Percutaneous Coronary Intervention For Complex Coronary Artery Disease Registry record

    Expected 2025-12-31; that period ended on 2025-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03381872

  37. Study completion Slow and Low Start of a Tacrolimus Once Daily Immunosuppressive Regimen Registry record

    Expected 2025-12; that period ended on 2025-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03672110

  38. Study completion Safety and Efficacy of AT-001 in Patients With Diabetic Cardiomyopathy Registry record

    Expected 2025-12; that period ended on 2025-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04083339

  39. Study completion Protection Against Emboli During Carotid Artery Stenting Using the Neuroguard IEP System Registry record

    Expected 2025-12; that period ended on 2025-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04201132

  40. Primary completion Ticagrelor With Low-dose Versus Regular Aspirin in Patients With Acute Coronary Syndrome (ACS) at High-Risk for Ischemia After Percutaneous Coronary Intervention Registry record

    Expected 2025-12; that period ended on 2025-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04240834

  41. Primary completion Left Atrial Posterior Wall Additional Isolation for Persistent Atrial Fibrillation Trial Registry record

    Expected 2025-12-31; that period ended on 2025-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04405258

  42. Primary completion Sirolimus Coated Balloon Versus Standard Balloon for SFA and Popliteal Artery Disease Registry record

    Expected 2025-12; that period ended on 2025-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04511234

  43. Study completion Home-Based SolUtion for Remote Atrial Fibrillation Screening to PrevenT RecUrrence StrOke (HUA-TUO AF Trial) Registry record

    Expected 2025-12-31; that period ended on 2025-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04523649

  44. Study completion ShorT and OPtimal Duration of Dual AntiPlatelet Therapy-3 Study Registry record

    Expected 2025-12-31; that period ended on 2025-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04609111

  45. Primary completion Early Antiplatelet Therapy After Hemorrhagic Infarction in Acute Ischemic Stroke Treated With Intravenous Thrombolysis (HITs) Registry record

    Expected 2025-12-31; that period ended on 2025-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04624295

  46. Primary completion European Blood Pressure Intensive Control After Stroke Registry record

    Expected 2025-12; that period ended on 2025-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04647292

  47. Study completion A Study of IV HBI-3000 for the Conversion Recent Onset Atrial Fibrillation (AF) Registry record

    Expected 2025-12-31; that period ended on 2025-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04680026

  48. Primary completion A Study of IV HBI-3000 for the Conversion Recent Onset Atrial Fibrillation (AF) Registry record

    Expected 2025-12-31; that period ended on 2025-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04680026

  49. Primary completion Safety of Continuing HER-2 Directed Therapy in Overt Left Ventricular Dysfunction Registry record

    Expected 2025-12-31; that period ended on 2025-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04680442

  50. Primary completion Renal Function After Stentgraft Treatment Of Abdominal Aortic Aneurysm Registry record

    Expected 2025-12; that period ended on 2025-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04754659

  51. Study completion OPtimizing Aldosterone Receptor Antagonist Therapy by Sodium Zirconium Cyclosilicate in Heart Failure Registry record

    Expected 2025-12-31; that period ended on 2025-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04789239

  52. Primary completion OPtimizing Aldosterone Receptor Antagonist Therapy by Sodium Zirconium Cyclosilicate in Heart Failure Registry record

    Expected 2025-12-31; that period ended on 2025-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04789239

  53. Study completion The Canadian Maraviroc Randomized Controlled Trial To Augment Rehabilitation Outcomes After Stroke Registry record

    Expected 2025-12; that period ended on 2025-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04789616

  54. Primary completion The Canadian Maraviroc Randomized Controlled Trial To Augment Rehabilitation Outcomes After Stroke Registry record

    Expected 2025-12; that period ended on 2025-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04789616

  55. Study completion Long-term Efficacy and Safety of OLE LIB003 in HoFH, HeFH, and High-risk CVD Patients Requiring Further LDL-C Reduction Registry record

    Expected 2025-12-31; that period ended on 2025-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04798430

  56. Study completion A Clinical Study of Insulin Degludec Injection in Subjects With Type 2 Diabetes Registry record

    Expected 2025-12-31; that period ended on 2025-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04955834

  57. Primary completion A Clinical Study of Insulin Degludec Injection in Subjects With Type 2 Diabetes Registry record

    Expected 2025-12-31; that period ended on 2025-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04955834

  58. Study completion For Patients With Ischemic Stroke, Clinically Study the Effectiveness and Safety of Butylphthalide. Registry record

    Expected 2025-12; that period ended on 2025-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05068349

  59. Study completion Effect Of Semaglutide In Coronary Atheroma Plaque Registry record

    Expected 2025-12; that period ended on 2025-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05071417

  60. Study completion Effect of Empagliflozin and Dulaglutide on MAFLD in Patients With T2D Registry record

    Expected 2025-12-31; that period ended on 2025-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05140694

  61. Study completion StrokeAlarm Trial 2 Registry record

    Expected 2025-12-31; that period ended on 2025-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05144932

  62. Primary completion StrokeAlarm Trial 2 Registry record

    Expected 2025-12-31; that period ended on 2025-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05144932

  63. Primary completion EndovaSCular TreAtment to imProve outcomEs for Medium Vessel Occlusions (ESCAPE-MeVO Trial) Registry record

    Expected 2025-12-31; that period ended on 2025-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05151172

  64. Study completion The Impact of Electroacupuncture Combined With NGF on Clinical Effect and Functional Changes on Ischemic Stroke Registry record

    Expected 2025-12-31; that period ended on 2025-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05231694

  65. Study completion Belgian Study to Assess the Efficacy and Safety of the RESTORER Iliac Stent for Treatment of Aorto-iliac Lesions. Registry record

    Expected 2025-12-31; that period ended on 2025-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05293002

  66. Primary completion Social Determinants and a Diabetes Prevention Program Tailored for African Americans Registry record

    Expected 2025-12-31; that period ended on 2025-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05301413

  67. Study completion MetCool ACS- Metformin Cooling Effect on Metformin-naive Patients Treated With PCI Because of Acute Coronary Syndrome Registry record

    Expected 2025-12; that period ended on 2025-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05305898

  68. Primary completion MetCool ACS- Metformin Cooling Effect on Metformin-naive Patients Treated With PCI Because of Acute Coronary Syndrome Registry record

    Expected 2025-12; that period ended on 2025-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05305898

  69. Primary completion The Value of IVL Compared To OPN Non-Compliant Balloons for Treatment of RefractorY Coronary Lesions (VICTORY) Trial Registry record

    Expected 2025-12-31; that period ended on 2025-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05346068

  70. Primary completion Treatment Preventive for Pre-eclampsia by Acetylsalicylic Acid in Women Who Underwent Frozen Embryo Transfer Registry record

    Expected 2025-12-31; that period ended on 2025-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05460416

  71. Study completion Kaneka Endovascular Embolization and Protection Registry record

    Expected 2025-12; that period ended on 2025-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05563051

  72. Primary completion Kaneka Endovascular Embolization and Protection Registry record

    Expected 2025-12; that period ended on 2025-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05563051

  73. Primary completion FlashPoint Renal Denervation Under Columbus 3D Mapping System Guidance for Treating Hypertension Registry record

    Expected 2025-12-31; that period ended on 2025-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05590871

  74. Primary completion Early Administration of Tirofiban in Patients Treated With Tenecteplase for Acute Ischemic Stroke Registry record

    Expected 2025-12-31; that period ended on 2025-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05604638

  75. Primary completion Effect of Tirzepatide on Progression of Coronary Atherosclerosis Using MDCT Registry record

    Expected 2025-12; that period ended on 2025-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05708859

  76. Study completion Stent Implantation Versus Balloon Dilation for Acute Anterior Circulation Tandem Occlusion Registry record

    Expected 2025-12; that period ended on 2025-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05902000

  77. Study completion Study on the Composite Endpoint Event of PCSK9 Inhibitor in Patients With Very High Risk of ASCVD and Cancer Registry record

    Expected 2025-12-31; that period ended on 2025-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05976893

  78. Primary completion Study on the Composite Endpoint Event of PCSK9 Inhibitor in Patients With Very High Risk of ASCVD and Cancer Registry record

    Expected 2025-12-31; that period ended on 2025-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05976893

  79. Primary completion Effect of Patient Management Based on Continuous Continuous Glucose Monitoring on Major Adverse Cardiovascular Events in Patients With Type 2 Diabetes and Moderate to Severe Coronary Artery Stenosis Registry record

    Expected 2025-12; that period ended on 2025-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06060483

  80. Primary completion Etomidate Versus Propofol in CABG Surgery Registry record

    Expected 2025-12; that period ended on 2025-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06068764

  81. Study completion Evolocumab in STEMI Registry record

    Expected 2025-12-31; that period ended on 2025-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06081803

  82. Primary completion Evolocumab in STEMI Registry record

    Expected 2025-12-31; that period ended on 2025-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06081803

  83. Primary completion Shuxuening Injection in the Treatment With Intravenous Thrombolysis in Patients With Ischemic Stroke (SHINY) Registry record

    Expected 2025-12-31; that period ended on 2025-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06157502

  84. Study completion Pulsed-field Ablation for Patients With Asymptomatic Non-paroxysmal Atrial Fibrillation Registry record

    Expected 2025-12-31; that period ended on 2025-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06166524

  85. Study completion Assessment of Cutting-Balloon Angioplasty With Everolimus-Eluting Stent(EES) in the Treatment of Coronary Calcified Lesion(CCL) Guided by Intravascular Ultrasonography(IVUS) Registry record

    Expected 2025-12-31; that period ended on 2025-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06177808

  86. Study completion Tongyuan Acupuncture on Consciousness Disorder After Stroke Registry record

    Expected 2025-12-31; that period ended on 2025-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06202833

  87. Primary completion Tongyuan Acupuncture on Consciousness Disorder After Stroke Registry record

    Expected 2025-12-31; that period ended on 2025-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06202833

  88. Study completion Henagliflozin in Relieving Type 2 Diabetes With Non-alcoholic Fatty Liver Disease Registry record

    Expected 2025-12-31; that period ended on 2025-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06218342

  89. Primary completion Henagliflozin in Relieving Type 2 Diabetes With Non-alcoholic Fatty Liver Disease Registry record

    Expected 2025-12-31; that period ended on 2025-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06218342

  90. Primary completion Phenotypic and Genotypic Characterization of Patients With Dysmetabolism in Greenland Registry record

    Expected 2025-12-31; that period ended on 2025-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06264427

  91. Study completion Optimal Medical Treatment of Difficult-to-treat Hypertension Registry record

    Expected 2025-12-31; that period ended on 2025-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06275763

  92. Study completion GD-11 for Injection in the Treatment of Acute Ischemic Stroke Registry record

    Expected 2025-12-31; that period ended on 2025-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06299579

  93. Study completion Real World Evaluation of Lifelight®: A Contactless Vital Signs Monitor for Self-monitoring Blood Pressure and Its Comparison to Standard of Care Registry record

    Expected 2025-12-31; that period ended on 2025-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06325384

  94. Study completion Efficacy and Safety of Sirolimus-coated Coronary Balloon Dilatation Catheter for Coronary Small Vessels Registry record

    Expected 2025-12; that period ended on 2025-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06345209

  95. Primary completion The Efficacy of Enavogliflozin in Heart Failure With Preserved Ejection Fraction Registry record

    Expected 2025-12-31; that period ended on 2025-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06350487

  96. Primary completion Interleukin-6 Receptor Inhibition for Symptomatic Intracranial Atherosclerosis Registry record

    Expected 2025-12-31; that period ended on 2025-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06447701

  97. Primary completion Beta-Blockers in Takotsubo Syndrome Study Registry record

    Expected 2025-12; that period ended on 2025-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06509074

  98. Study completion Continuous Glucose Monitoring for Glucose and Weight Management in Prediabetes and Non-severe Type 2 Diabetes: A Prospective Community-based (Workplace) Cohort Study Registry record

    Expected 2025-12-31; that period ended on 2025-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06542627

  99. Primary completion Continuous Glucose Monitoring for Glucose and Weight Management in Prediabetes and Non-severe Type 2 Diabetes: A Prospective Community-based (Workplace) Cohort Study Registry record

    Expected 2025-12-31; that period ended on 2025-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06542627

  100. Primary completion Colchicine in Patients With Heart Failure With Preserved Ejection Fraction and Inflammation Registry record

    Expected 2025-12-31; that period ended on 2025-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06604611